Literature DB >> 14531845

Using protein-based motifs to stabilize peptides.

J R Walker1, R K Altman, J W Warren, E Altman.   

Abstract

While the use of synthetically derived novel inhibitor peptides as a source of new therapeutics for medicine remains incredibly promising, there is a major problem with implementing this technology, as many synthetic peptides have proven to be unstable and are degraded by peptidases in the host cell. In this study, we have investigated methods by which peptides can be stabilized using protein-based motifs in order to prevent the action of peptidases. Using an in vivo approach our laboratory developed to screen for synthetic peptides which can inhibit the growth of Escherichia coli, we found that protecting the amino or carboxyl terminus of the peptides via fusion to the very stable Rop protein, or the incorporation of two proline residues, increased the frequency at which potent inhibitor peptides could be isolated. Using an in vitro degradation assay in which extracts from several different cell types were tested, we demonstrated that peptides stabilized with multiple proline residues were more resistant to degradation than peptides stabilized by amidation or acetylation, two approaches that are routinely utilized to improve the stability of peptide drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531845     DOI: 10.1034/j.1399-3011.2003.00085.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  10 in total

1.  Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Vaccine       Date:  2007-01-17       Impact factor: 3.641

2.  Biotinylation facilitates the uptake of large peptides by Escherichia coli and other gram-negative bacteria.

Authors:  Jennifer R Walker; Elliot Altman
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

Review 3.  Design of growth factor sequestering biomaterials.

Authors:  David G Belair; Ngoc Nhi Le; William L Murphy
Journal:  Chem Commun (Camb)       Date:  2014-09-03       Impact factor: 6.222

4.  Conformational profile of a proline-arginine hybrid.

Authors:  Guillermo Revilla-López; Ana I Jiménez; Carlos Cativiela; Ruth Nussinov; Carlos Alemán; David Zanuy
Journal:  J Chem Inf Model       Date:  2010-10-25       Impact factor: 4.956

5.  Specific VEGF sequestering to biomaterials: influence of serum stability.

Authors:  David G Belair; William L Murphy
Journal:  Acta Biomater       Date:  2013-06-29       Impact factor: 8.947

6.  In silico molecular engineering for a targeted replacement in a tumor-homing peptide.

Authors:  David Zanuy; Alejandra Flores-Ortega; Ana I Jiménez; M Isabel Calaza; Carlos Cativiela; Ruth Nussinov; Erkki Ruoslahti; Carlos Alemán
Journal:  J Phys Chem B       Date:  2009-06-04       Impact factor: 2.991

7.  ACTH(6-9)PGP Peptide Protects SH-SY5Y Cells from H2O2, tert-Butyl Hydroperoxide, and Cyanide Cytotoxicity via Stimulation of Proliferation and Induction of Prosurvival-Related Genes.

Authors:  Mikhail G Akimov; Elena V Fomina-Ageeva; Polina V Dudina; Ludmila A Andreeva; Nikolay F Myasoyedov; Vladimir V Bezuglov
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

8.  L-Tyrosine Confers Residualizing Properties to a d-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.

Authors:  Fook T Lee; Ingrid J G Burvenich; Nancy Guo; Pece Kocovski; Henri Tochon-Danguy; Uwe Ackermann; Graeme J O'Keefe; Sylvia Gong; Angela Rigopoulos; Zhanqi Liu; Hui K Gan; Andrew M Scott
Journal:  Mol Imaging       Date:  2016-07-25       Impact factor: 4.488

9.  Antibacterial Activity of the Non-Cytotoxic Peptide (p-BthTX-I)₂ and Its Serum Degradation Product against Multidrug-Resistant Bacteria.

Authors:  Norival A Santos-Filho; Rafaela S Fernandes; Bruna F Sgardioli; Matheus A S Ramos; Julia P Piccoli; Ilana L B C Camargo; Tais M Bauab; Eduardo M Cilli
Journal:  Molecules       Date:  2017-11-04       Impact factor: 4.411

10.  Redesigned reporter gene for improved proton exchange-based molecular MRI contrast.

Authors:  Or Perlman; Hirotaka Ito; Assaf A Gilad; Michael T McMahon; E Antonio Chiocca; Hiroshi Nakashima; Christian T Farrar
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.